Clene price target lowered to $83 from $86 at Canaccord
Canaccord analyst Sumant Kulkarni lowered the firm’s price target on Clene (CLNN) to $83 from $86 and keeps a Buy rating on the shares. The firm noted they reported results with the key update for that the company held its planned meeting with the FDA on Novemebr 01 to discuss the potential to file a new drug application (NDA) for CNM-Au8 (nanocrystalline gold) for amyotrophic lateral sclerosis (ALS) under an accelerated approval pathway.
Zeta Global price target lowered to $24 from $42 at Canaccord
Canaccord analyst David Hynes lowered the firm’s price target on Zeta Global (ZETA) to $24 from $42 and keeps a Buy rating on the shares.
Canaccord Genuity Group (TSE:CF) Price Target Raised to C$12.00
Canaccord Genuity Group (TSE:CF – Free Report) had its price target raised by TD Securities from C$10.00 to C$12.00 in a research note released on Tuesday,BayStreet.CA reports. Several other equities analysts have also commented on the company.
Spotify price target raised to $525 from $475 at Canaccord
Canaccord analyst Maria Ripps raised the firm’s price target on Spotify (SPOT) to $525 from $475 and keeps a Buy rating on the shares. The firm said they reported generally solid Q3 results, with MAUs and Premium Subscribers broadly in line with consensus,
Ayr Wellness price target lowered to C$4.75 from C$6 at Canaccord
Canaccord analyst Matt Bottomley lowered the firm’s price target on Ayr Wellness (AYRWF) to C$4.75 from C$6 and keeps a Speculative Buy
Cormark Increases Canaccord Genuity Group (TSE:CF) Price Target to C$12.50
Canaccord Genuity Group (TSE:CF – Free Report) had its target price lifted by Cormark from C$11.50 to C$12.50 in a report issued on Tuesday,BayStreet.CA reports. Cormark also issued estimates for Canaccord Genuity Group’s Q3 2025 earnings at $0.
Natera price target raised to $165 from $150 at Canaccord
Canaccord raised the firm’s price target on Natera (NTRA) to $165 from $150 and keeps a Buy rating on the shares. The firm remains “highly
Nvidia price target raised to $160 from $138 at Wedbush
Wedbush analyst Matt Bryson raised the firm’s price target on Nvidia (NVDA) to $160 from $138 and keeps an Outperform rating on the
Canaccord Genuity lures Ottawa team from CIBC
Canaccord Genuity Group Inc. CF-T -0.59% has lured a team of advisers with $1-billion of client assets from Canadian Imperial ...
Hosted on MSN1d
Doximity downgraded at Canaccord after recent rally
Canaccord Genuity on Wednesday downgraded Doximity (NYSE:DOCS) to hold from buy, noting that its shares, after a more than ...
bovnews15h
Canaccord Genuity Issues Buy Rating for Blend Labs Inc (BLND) Stock
On Wednesday, Blend Labs Inc (BLND) stock saw a decline, ending the day at $4.36 which represents a decrease of $-0.19 or -4.18% from the prior close of $4.55. The stock opened at $4.59 and touched a ...
wealthprofessional.ca3d
Canaccord Genuity posts record Q2 in wealth management, capital markets rise
Canaccord Genuity Group Inc. recorded strong growth in wealth-management and capital-markets divisions for its fiscal second ...
Hosted on MSN1d
Canaccord Genuity Downgrades Doximity (DOCS)
Fintel reports that on November 13, 2024, Canaccord Genuity downgraded their outlook for Doximity (NYSE:DOCS) from Buy to ...
Canaccord Meets Second-Quarter Estimates as Revenue Surges 27%
(Bloomberg) -- Canaccord Genuity Group Inc. posted record wealth-management numbers in its fiscal second quarter and said its capital-markets division is also bouncing back after an extended down ...
The Mining Journal6h
Keep faith in gold: Canaccord
Despite gold's recent decline, major ASX resource sector fundraiser Canaccord Capital is still convinced the metal remains the commodity of choice going into ...